摘要
Objective
To evaluate the association of body mass index (BMI) with cycle outcomes after euploid frozen blastocyst transfer. Design
Retrospective cohort study. Setting
Not applicable. Patient(s)
A total of 56,564 first single autologous euploid frozen embryo transfers from the 2016–2019 Society for Assisted Reproductive Technology database were analyzed using BMI and using World Health Organization BMI cohorts. Subanalyses were performed on cycles among patients with a sole diagnosis of polycystic ovary syndrome (PCOS) (n = 4,626) and among patients with only a male factor (n = 10,854). Intervention(s)
None. Main Outcome Measure(s)
Clinical pregnancy, pregnancy loss, and live birth (LB). Result(s)
Success rates and adjusted odds ratios (aORs) with 95% confidence intervals (CIs) for all outcomes were most favorable among those with normal BMI and progressively worsened with increasing BMI. These trends persisted among patients with PCOS for clinical pregnancy (aOR, 0.99; 95% CI, 0.98–0.997), pregnancy loss (aOR, 1.02; 95% CI, 1.01–1.04), and LB (aOR, 0.98; 95% CI, 0.97–0.99), but not among patients with a male factor only for clinical pregnancy (aOR, 1.00; 95% CI, 0.99–1.01), pregnancy loss (aOR, 1.01; 95% CI, 0.99–1.03), or LB (aOR, 0.99; 95% CI, 0.98–1.00). Conclusion(s)
In the largest cohort to date, increasing BMI was associated with decreased pregnancy and LB and increased pregnancy loss after euploid frozen embryo transfers among the entire cohort and among patients with a sole diagnosis of PCOS; however, these results were attenuated among patients with a sole diagnosis of male factor infertility, suggesting that associated female infertility diagnoses and not BMI alone may underlie this trend.